JP2008539164A - レプリキンペプチド及びその使用 - Google Patents

レプリキンペプチド及びその使用 Download PDF

Info

Publication number
JP2008539164A
JP2008539164A JP2007555371A JP2007555371A JP2008539164A JP 2008539164 A JP2008539164 A JP 2008539164A JP 2007555371 A JP2007555371 A JP 2007555371A JP 2007555371 A JP2007555371 A JP 2007555371A JP 2008539164 A JP2008539164 A JP 2008539164A
Authority
JP
Japan
Prior art keywords
replikin
lysine
peptide
amino acid
influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007555371A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008539164A5 (enExample
Inventor
ボゴーク，サミュエル
エス． ボゴーク，エレノア
ウィンストン ボゴーク，サミュエル
ボゴーク ボルサンニ，アン−エレノア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/014443 external-priority patent/WO2005104754A2/en
Application filed by Individual filed Critical Individual
Publication of JP2008539164A publication Critical patent/JP2008539164A/ja
Publication of JP2008539164A5 publication Critical patent/JP2008539164A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hematology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
JP2007555371A 2005-02-16 2006-02-16 レプリキンペプチド及びその使用 Pending JP2008539164A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65308305P 2005-02-16 2005-02-16
PCT/US2005/014443 WO2005104754A2 (en) 2004-04-28 2005-04-28 System and method for identifying complex patterns of amino acids
PCT/US2006/005343 WO2006088962A2 (en) 2005-02-16 2006-02-16 Replikin peptides and uses thereof

Publications (2)

Publication Number Publication Date
JP2008539164A true JP2008539164A (ja) 2008-11-13
JP2008539164A5 JP2008539164A5 (enExample) 2009-04-09

Family

ID=36917023

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007555371A Pending JP2008539164A (ja) 2005-02-16 2006-02-16 レプリキンペプチド及びその使用

Country Status (8)

Country Link
EP (1) EP1859063A4 (enExample)
JP (1) JP2008539164A (enExample)
AU (1) AU2006214332B2 (enExample)
CA (1) CA2598381A1 (enExample)
IL (1) IL185308A0 (enExample)
NZ (1) NZ560415A (enExample)
SG (1) SG160327A1 (enExample)
WO (1) WO2006088962A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
CA2653702A1 (en) * 2006-05-30 2008-05-22 Samuel Bogoch Replikin peptides and uses thereof
EP2092059A4 (en) 2006-10-24 2012-03-28 Bogoch Samuel METHOD FOR FORECASTING INFLUENZA EXCESSIONS BY CORRELATION OF AN INCREASED REPLICINE MIRROR IN WHITE SPOT AND / OR TAURA VIRUSES IN CRABES
US20090017052A1 (en) 2007-01-18 2009-01-15 Samuel Bogoch Methods of determining lethality of pathogens and malignancies involving replikin peak genes
MX2009013091A (es) * 2007-05-30 2010-07-30 Bogoch Samuel Peptidos de repliquina sinteticos contra infeccion patogenica de invertebrados en acuicultura.
EP2300493A2 (en) * 2008-04-23 2011-03-30 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
EP2320932B1 (en) * 2008-08-08 2015-07-15 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
EP2421546A1 (en) * 2009-04-23 2012-02-29 Samuel Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
CA2842345A1 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
US20130243803A1 (en) 2012-03-09 2013-09-19 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005010032A2 (en) * 2003-06-06 2005-02-03 Samuel Bogoch Replikin peptides and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0221748A3 (en) 1985-11-01 1988-10-12 Samuel Dr. Bogoch A process for the production of human antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6242578B1 (en) 1994-02-17 2001-06-05 Samuel Bogoch Aglyco products and methods of use
US7420028B2 (en) * 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US11620305B2 (en) 2021-03-25 2023-04-04 Salesforce.Com, Inc Ruleset engine for generating homogeneous data sets

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005010032A2 (en) * 2003-06-06 2005-02-03 Samuel Bogoch Replikin peptides and uses thereof

Also Published As

Publication number Publication date
WO2006088962A2 (en) 2006-08-24
WO2006088962A9 (en) 2006-11-16
EP1859063A4 (en) 2012-02-01
WO2006088962A3 (en) 2008-01-24
EP1859063A2 (en) 2007-11-28
SG160327A1 (en) 2010-04-29
CA2598381A1 (en) 2006-08-24
AU2006214332B2 (en) 2012-03-22
IL185308A0 (en) 2008-02-09
NZ560415A (en) 2010-05-28
AU2006214332A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
US7894999B2 (en) Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
AU2010200602B2 (en) Replikin peptides and uses thereof
AU2002309514B2 (en) Replikin peptides and uses thereof
US20070053916A1 (en) Replikin peptides in rapid replication of glioma cells and in influenza epidemics
US9388234B2 (en) Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
AU2002309514A1 (en) Replikin peptides and uses thereof
JP5174014B2 (ja) レプリキンペプチドおよびその使用
JP2006500001A (ja) レプリキンペプチドとその使用
AU2006214332B2 (en) Replikin peptides and uses thereof
KR100906102B1 (ko) 레플리킨 펩타이드 및 그의 이용
JP2004535171A (ja) レプリキンペプチドおよびその使用
US9254315B2 (en) Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
NZ584367A (en) Systems and methods for indentifying Replikin scaffolds and uses of said Replikin scaffolds
KR101067654B1 (ko) 레플리킨 펩타이드 및 그의 이용
HK1141032A (en) Replikin peptides and uses thereof

Legal Events

Date Code Title Description
A59 Written plea

Free format text: JAPANESE INTERMEDIATE CODE: A59

Effective date: 20080820

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090209

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090209

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110719

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120117